(Q39169802)

9 September 2017

title

pH-controlled delivery of nanoparticles into tumor cells (English)

1 reference

9 September 2017

0 references

Liang Han

1

1 reference

9 September 2017

Haojun Ma

2

1 reference

9 September 2017

Yubo Guo

3

1 reference

9 September 2017

Yuyang Kuang

4

1 reference

9 September 2017

Xi He

5

1 reference

9 September 2017

Chen Jiang

6

1 reference

9 September 2017

publication date

8 April 2013

1 reference

Advanced Healthcare Materials

9 September 2017

published in

1 reference

9 September 2017

volume

2

1 reference

9 September 2017

issue

11

1 reference

9 September 2017

page(s)

1435-1439

1 reference

Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Assessment of normal and tumor tissue uptake of MAG-CPT, a polymer-bound prodrug of camptothecin, in patients undergoing elective surgery for colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Drug delivery systems: entering the mainstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Cancer genome sequencing--an interim analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Is anticancer drug development heading in the right direction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Tumor pH and its measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Enhancement of chemotherapy by manipulation of tumour pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

A novel technology for the imaging of acidic prostate tumors by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

pHLIP-mediated translocation of membrane-impermeable molecules into cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Bilayer interactions of pHLIP, a peptide that can deliver drugs and target tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Accurate analysis of tumor margins using a fluorescent pH Low Insertion Peptide (pHLIP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Energetics of peptide (pHLIP) binding to and folding across a lipid bilayer membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Ligand-targeted therapeutics in anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

pH-controlled delivery of luminescent europium coated nanoparticles into platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Choline-derivate-modified nanoparticles for brain-targeting gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

pH (low) insertion peptide (pHLIP) inserts across a lipid bilayer as a helix and exits by a different path

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Anti-VEGF agents confer survival advantages to tumor-bearing mice by improving cancer-associated systemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

Antiangiogenic agents significantly improve survival in tumor-bearing mice by increasing tolerance to chemotherapy-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300013

21 January 2018

Identifiers

DOI

10.1002/ADHM.201300013

1 reference

9 September 2017

1 reference